Atrial Fibrillation
📧 Sign up to get email alerts when something new happens for Atrial Fibrillation.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2015-11-25Clinical Trial Update: A Study of Strategies for Electrical Isolation of Pulmonic Veins for Curative Treatment of Atrial Fibrillation [NA]
The clinical trial evaluating strategies for electrical isolation of the pulmonic veins as a curative treatment for atrial fibrillation has …
-
CLINICAL_TRIALS research · 2015-11-23Clinical Trial Update: Effect of Cryoballoon and RF Ablation on Left Atrial Function [NA]
This clinical trial update examines how cryoballoon and radiofrequency ablation affect left atrial function in people with atrial fibrillati…
-
FDA approval · 2015-11-20FDA Approved: DILTIAZEM HYDROCHLORIDE EXTENDED RELEASE — Supplemental Application (Oceanside Pharmaceuticals)
FDA approved a supplemental application for diltiazem hydrochloride extended-release from Oceanside Pharmaceuticals.
-
CLINICAL_TRIALS trial_result · 2015-11-20Clinical Trial Update: Ablation or Surgery for Atrial Fibrillation (AF) Treatment [NA]
The clinical trial comparing ablation and surgical treatment for atrial fibrillation has completed.
-
CLINICAL_TRIALS research · 2015-11-13Clinical Trial Update: Surgical Ablation of Long-standing Persistent AF During CABG [Phase 3]
Phase 3 clinical trial evaluating surgical ablation of long-standing persistent atrial fibrillation during CABG in patients with coronary ar…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2015-11-13Clinical Trial Update: Left Atrial Thrombus Reduction - Effect of Dabigatran Versus Phenprocoumon [Phase 4]
Phase 4 trial comparing dabigatran to phenprocoumon for left atrial thrombus reduction in atrial fibrillation; the current status is unknown…
-
CLINICAL_TRIALS trial_result · 2015-11-11Clinical Trial Update: Real-Life Evidence on Stroke Prevention in SPAF
A Bayer-sponsored trial providing real-world evidence on stroke prevention in patients with atrial fibrillation has completed. The update su…
-
CLINICAL_TRIALS trial_result · 2015-11-10Clinical Trial Update: A Study Exploring Two Treatment Strategies in Patients With Atrial Fibrillation Who Undergo Catheter Ablation Therapy [Phase 3]
Phase 3 trial evaluating two treatment strategies in patients with atrial fibrillation undergoing catheter ablation; results posted in 2015.
-
FDA approval · 2015-10-26FDA Approved: VERAPAMIL HYDROCHLORIDE — Supplemental Application (Actavis Pharma, Inc.)
The FDA approved a supplemental application for verapamil hydrochloride (Actavis Pharma, Inc.), a generic product.
-
FDA approval · 2015-10-26FDA Approved: XARELTO — Supplemental Application (Janssen Pharmaceuticals, Inc.)
FDA approved a supplemental application for XARELTO (rivaroxaban) submitted by Janssen Pharmaceuticals, Inc.
-
FDA approval · 2015-10-14FDA Approved: VERAPAMIL HYDROCHLORIDE — Supplemental Application (Chartwell RX, LLC)
FDA approved a supplemental application for Verapamil Hydrochloride (generic) from Chartwell RX, LLC.
-
CLINICAL_TRIALS trial_result · 2015-10-12Clinical Trial Update: Pacemaker Holter Assessment of the Effect of BMS-914392 on Atrial Fibrillation Burden [Phase 2]
A Phase 2 trial evaluated the effect of BMS-914392 on atrial fibrillation burden using pacemaker Holter assessment; the study is completed.
-
CLINICAL_TRIALS trial_result · 2015-10-12Clinical Trial Update: Dabigatran's Effect on Changes in Atrial Fibrosis in Patients With Atrial Fibrillation [Phase 4]
Phase 4 trial evaluated dabigatran's effect on changes in atrial fibrosis in patients with atrial fibrillation; the study was terminated and…
-
CLINICAL_TRIALS research · 2015-10-12Clinical Trial Update: Non-invasive Blood Pressure and Cardiac Output Measurement by Using Applanation Tonometry
This entry provides an update on a clinical trial evaluating non-invasive blood pressure and cardiac output measurement using applanation to…
-
CLINICAL_TRIALS trial_result · 2015-10-09Clinical Trial Update: Dabigatran Versus Warfarin After Mitral and/or Aortic Bioprosthesis Replacement and Atrial Fibrillation Postoperatively [Phase 2, Phase 3]
This clinical trial compares dabigatran to warfarin after bioprosthetic valve replacement in patients with atrial fibrillation. The Phase 2/…
-
CLINICAL_TRIALS trial_result · 2015-10-06Clinical Trial Update: Safe Use of New Oral Anticoagulants in Ablation for Atrial Fibrillation
This clinical trial update reports on the safe use of new oral anticoagulants during ablation procedures for atrial fibrillation.
-
FDA approval · 2015-10-05FDA Approved: AMIODARONE HYDROCHLORIDE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
The FDA approved a supplemental application for amiodarone hydrochloride submitted by Sun Pharmaceutical Industries, Inc.
-
CLINICAL_TRIALS trial_result · 2015-10-05Clinical Trial Update: A Prospective, Open Label Study Evaluating Two Management Strategies on Gastrointestinal Symptoms in Patients Newly on Treatment With Pradaxa for the Prevention of Stroke and Systemic Embolism With Non-valvular Atrial Fibrillation [Phase 4]
Phase 4 trial evaluating two management strategies for gastrointestinal symptoms in patients newly on Pradaxa (dabigatran) for stroke preven…
-
CLINICAL_TRIALS trial_result · 2015-09-29Clinical Trial Update: Effect of Left Atrial Appendage Excision on Procedure Outcome in Patients With Persistent and Long-standing Persistent Atrial Fibrillation Undergoing Surgical Ablation [Phase 2]
A Phase 2 clinical trial investigates whether excising the left atrial appendage during surgical ablation affects outcomes in patients with …
-
FDA label_change · 2015-09-25FDA Approved: SOTALOL HYDROCHLORIDE — Supplemental Application (ALTATHERA Pharmaceuticals, LLC)
The FDA approved a supplemental application for Sotalol Hydrochloride submitted by ALTATHERA Pharmaceuticals, LLC, to modify the product lab…
-
CLINICAL_TRIALS trial_result · 2015-09-24Clinical Trial Update: Evaluation of WATCHMAN Left Atrial Appendage Occlusion Device in Patients With Atrial Fibrillation Versus Rivaroxaban [Phase 4]
Phase 4 study evaluating the WATCHMAN left atrial appendage occlusion device compared with rivaroxaban for patients with atrial fibrillation…
-
CLINICAL_TRIALS trial_result · 2015-09-23Clinical Trial Update: Pulmonary Vein Isolation Versus Botulinum Toxin Injection Plus Pulmonary Vein Isolation in Patients With Atrial Fibrillation [Phase 2]
Phase 2 clinical trial comparing Pulmonary Vein Isolation alone versus Botulinum toxin injection plus Pulmonary Vein Isolation in patients w…
-
CLINICAL_TRIALS trial_result · 2015-09-23Clinical Trial Update: Comparison of Redo PVI With vs. Without Renal Denervation for Recurrent AF After Initial PVI [Phase 2]
This Phase 2 trial compares redo pulmonary vein isolation for recurrent atrial fibrillation after an initial PVI, with and without renal den…
-
CLINICAL_TRIALS trial_result · 2015-09-23Clinical Trial Update: Left Atrial Appendage Occlusion Study II [Phase 3]
Phase 3 trial update for left atrial appendage occlusion in patients with atrial fibrillation, with the study status showing as completed.
-
CLINICAL_TRIALS research · 2015-09-23Clinical Trial Update: Endomyocardial Botulinum Toxin Injection in Patients With Persistent Atrial Fibrillation [Phase 2]
Phase 2 clinical trial update evaluating endomyocardial botulinum toxin injections in patients with persistent atrial fibrillation. No resul…